Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A decade of clinical development of PARP inhibitors in perspective.
Mateo J, Lord CJ, Serra V, Tutt A, Balmaña J, Castroviejo-Bermejo M, Cruz C, Oaknin A, Kaye SB, de Bono JS. Mateo J, et al. Among authors: balmana j. Ann Oncol. 2019 Sep 1;30(9):1437-1447. doi: 10.1093/annonc/mdz192. Ann Oncol. 2019. PMID: 31218365 Free PMC article. Review.
BRCA in breast cancer: ESMO clinical recommendations.
Balmaña J, Díez O, Castiglione M; ESMO Guidelines Working Group. Balmaña J, et al. Ann Oncol. 2009 May;20 Suppl 4:19-20. doi: 10.1093/annonc/mdp116. Ann Oncol. 2009. PMID: 19454451 Free article. Review. No abstract available.
BRCA in breast cancer: ESMO Clinical Practice Guidelines.
Balmaña J, Diez O, Rubio I, Castiglione M; ESMO Guidelines Working Group. Balmaña J, et al. Ann Oncol. 2010 May;21 Suppl 5:v20-2. doi: 10.1093/annonc/mdq161. Ann Oncol. 2010. PMID: 20555082 Free article. No abstract available.
BRCA in breast cancer: ESMO Clinical Practice Guidelines.
Balmaña J, Díez O, Rubio IT, Cardoso F; ESMO Guidelines Working Group. Balmaña J, et al. Ann Oncol. 2011 Sep;22 Suppl 6:vi31-4. doi: 10.1093/annonc/mdr373. Ann Oncol. 2011. PMID: 21908500 Free article. No abstract available.
Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer.
Domchek SM, Mitchell G, Lindeman GJ, Tung NM, Balmaña J, Isakoff SJ, Schmutzler R, Audeh MW, Loman N, Scott C, Friedlander M, Kaufman B, Garber JE, Tutt A, Robson ME. Domchek SM, et al. Among authors: balmana j. J Clin Oncol. 2011 Nov 10;29(32):4224-6. doi: 10.1200/JCO.2011.36.8134. Epub 2011 Sep 19. J Clin Oncol. 2011. PMID: 21931031 No abstract available.
Management of the axilla in early breast cancer patients in the genomic era.
Oliveira M, Cortés J, Bellet M, Balmaña J, De Mattos-Arruda L, Gómez P, Muñoz E, Ortega V, Pérez J, Saura C, Vidal M, Rubio IT, Di Cosimo S. Oliveira M, et al. Among authors: balmana j. Ann Oncol. 2013 May;24(5):1163-70. doi: 10.1093/annonc/mds592. Epub 2012 Nov 19. Ann Oncol. 2013. PMID: 23165977 Free article. Review.
Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines.
Balmaña J, Balaguer F, Cervantes A, Arnold D; ESMO Guidelines Working Group. Balmaña J, et al. Ann Oncol. 2013 Oct;24 Suppl 6:vi73-80. doi: 10.1093/annonc/mdt209. Epub 2013 Jun 27. Ann Oncol. 2013. PMID: 23813931 Free article. No abstract available.
225 results